149 results
8-K
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
for all performance objectives) (the “Unvested CVR Consideration”), less any required deductions and withholdings for income tax and National Insurance
8-K
EX-2.2
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
of the Transaction Agreement) and Rights Agent may require payment of a sum sufficient to cover any stamp duty or other transfer Tax or charge that is imposed … , Purchaser or any of its Subsidiaries is required under Applicable Law to deduct or withhold any employee Tax (including any employee National Insurance
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
or tax advice.
Orchard shareholders may not use any electronic address or fax number provided in this Notice or in any related documents … deliverables, when used in relation to holders of Orchard ADSs.
“VAT” means (i) any tax charged or imposed pursuant to Council Directive 2006/112/EC
8-K
ORTX
Orchard Therapeutics plc
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
Court of Justice of England and Wales, satisfaction of other closing conditions to consummate the acquisition, anticipated tax treatment, unforeseen … and market developments and conditions; (xi) the evolving legal, regulatory and tax regimes under which Orchard operates; (xii) potential business uncertainty
8-K
EX-99.1
hac4yhd4c34kmg9 y66
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
PREM14A
3y008npute
3 Nov 23
Preliminary proxy related to merger
5:11pm
DEFA14A
kky ks9wcnwp16
17 Oct 23
Additional proxy soliciting materials
4:32pm
DEFA14C
14y 4udwlcajlmq9
5 Oct 23
Additional information
5:26pm
DEFA14C
vl5229e
5 Oct 23
Additional information
4:48pm
DEFA14C
mr5u mjwlebl
5 Oct 23
Additional information
4:45pm
DEFA14C
rvj tqyq8k1cuo2k92s
5 Oct 23
Additional information
4:43pm
DEFA14C
434k0n
5 Oct 23
Additional information
4:40pm
DEFA14A
59hccqws99fg h3bim
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
EX-2.1
1oxo0wgnm5opcrstv
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-10.1
qhsxyevlw yl9
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
qfzbdjihq
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-99.1
1tbwgvkxs4q6ih rj
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
424B3
3nq0 09vq108jyozl74
21 Aug 23
Prospectus supplement
4:32pm
S-8
EX-5.1
u7tw70iyp86mab3qn 80
10 Aug 23
Registration of securities for employees
5:04pm